Related Experiment Video
Updated: Feb 10, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Impact of Uncontrolled Hypertension on Atrial Fibrillation Ablation Outcome
Francesco Santoro1, Luigi Di Biase2, Chintan Trivedi3
1Department of Cardiology, University of Foggia, Foggia, Italy; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.
Insights
Uncontrolled hypertension increases atrial fibrillation (AF) recurrence after ablation. Controlled hypertension shows similar outcomes to no hypertension, suggesting tailored ablation strategies are needed for hypertensive AF patients.
Area of Science:
- Cardiology
- Electrophysiology
- Hypertension Research
Background:
- Hypertension is a significant risk factor for developing atrial fibrillation (AF).
- Understanding hypertension's impact on AF ablation outcomes is crucial for patient management.
Purpose of the Study:
- To assess how hypertension affects the success rates of atrial fibrillation ablation.
- To compare AF ablation outcomes in patients with uncontrolled hypertension, controlled hypertension, and no hypertension.
Main Methods:
- 531 patients undergoing AF ablation were categorized into three groups: uncontrolled hypertension, controlled hypertension, and no hypertension.
- Pulmonary vein antrum and posterior wall isolation were performed, with identification of non-pulmonary vein triggers.
- Follow-up averaged 19 months to assess arrhythmia recurrence.
Main Results:
- Uncontrolled hypertension was associated with larger left atrial size and more non-pulmonary vein triggers.
- AF recurrence rates were significantly higher in the uncontrolled hypertension group (40.6%) compared to controlled (28.1%) and no hypertension (25.7%) groups.
- Uncontrolled hypertension, non-pulmonary vein triggers, and nonparoxysmal AF were independent predictors of recurrence.
Conclusions:
- Controlled hypertension does not negatively impact AF ablation outcomes.
- Uncontrolled hypertension significantly increases the risk of AF recurrence post-ablation.
- Patients with uncontrolled hypertension may benefit from more extensive ablation procedures targeting additional triggers.
Objectives:
The goal of this study was to evaluate the impact of hypertension on the outcome of atrial fibrillation (AF) ablation.
Background:
Hypertension is a well-known independent risk factor for incident AF.
Methods:
A total of 531 consecutive patients undergoing AF ablation were enrolled in this study and divided into 3 groups: patients with uncontrolled hypertension despite medical treatment (group I, n = 160), patients with controlled hypertension (group II, n = 192), and patients without hypertension (group III, n = 179). Pulmonary vein (PV) antrum and posterior wall isolation was always performed, and non-PV triggers were identified during isoproterenol infusion. All patients underwent extensive follow-up.
Results:
Three groups differed in terms of left atrial (LA) size, non-PV triggers, and moderate/severe LA scar. Non-PV triggers were present in 94 (58.8%), 64 (33.3%), and 50 (27.9%) patients in groups I, II, and III, respectively (p < 0.001). After 19 ± 7.7 months of follow-up, 65 (40.6%), 54 (28.1%), and 46 (25.7%) patients in groups I, II, and III had recurrences (log-rank test, p = 0.003). Among patients in group I who underwent additional non-PV trigger ablation, freedom from AF/atrial tachycardia was 69.8%, which was similar to groups II and III procedural success (log-rank p = 0.7). After adjusting for confounders, uncontrolled hypertension (group I) (hazard ratio [HR]: 1.52, p = 0.045), non-PV triggers (HR: 1.85, p < 0.001), and nonparoxysmal AF (HR: 1.64, p = 0.002) demonstrated significant association with arrhythmia recurrence.
Conclusions:
Controlled hypertension does not affect the AF ablation outcome when compared with patients without hypertension. By contrast, uncontrolled hypertension confers higher AF recurrence risk and requires more extensive ablation.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Predicting Reaction Outcomes
Impact of Groups on Groups
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

